Integrated BioPharma (OTCMKTS:INBP) Trading Down 5.5% – Time to Sell?

Integrated BioPharma Inc. (OTCMKTS:INBP)’s stock price dropped 5.5% during trading on Monday . The company traded as low as $0.2890 and last traded at $0.3199. Approximately 46,504 shares traded hands during mid-day trading, an increase of 352% from the average daily volume of 10,290 shares. The stock had previously closed at $0.3385.

Integrated BioPharma Stock Performance

The company has a quick ratio of 1.92, a current ratio of 4.12 and a debt-to-equity ratio of 0.01. The stock has a fifty day moving average of $0.33 and a 200-day moving average of $0.31. The stock has a market cap of $9.91 million, a PE ratio of 32.02 and a beta of 0.53.

Integrated BioPharma Company Profile

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products.